EP Patent

EP1329458A2 — Peptides that lower blood glucose levels

Assigned to Zealand Pharma AS · Expires 2003-07-23 · 23y expired

What this patent protects

The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.

USPTO Abstract

The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.

Drugs covered by this patent

Patent Metadata

Patent number
EP1329458A2
Jurisdiction
EP
Classification
—
Expires
2003-07-23
Drug substance claim
No
Drug product claim
No
Assignee
Zealand Pharma AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.